<html><body><h2>Case: 1177595</h2><h3> CDS Time: 2011-05-31</h3>
<patient name=1177595>
78.0 year old Asian_or_Pacific-Islander_Non-Hispanic Female
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">78</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">UrineProtein_12h</td><td width="200">1,088</td><td width="200">1977-9-16</td></tr>
<tr><td width="200">Calcium</td><td width="200">6</td><td width="200">1978-9-19</td></tr>
<tr><td width="200">UrineProtein_24h</td><td width="200">1,088</td><td width="200">1977-9-16</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">122</td><td width="200">1978-9-19</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">10</td><td width="200">1978-9-19</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">65</td><td width="200">1978-9-13</td></tr>
<tr><td width="200">Chloride</td><td width="200">102.0</td><td width="200">1978-9-19</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">53</td><td width="200">1978-9-13</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">70</td><td width="200">1978-9-13</td></tr>
<tr><td width="200">Weight</td><td width="200">162</td><td width="200">1978-9-13</td></tr>
<tr><td width="200">Uric_Acid</td><td width="200">8</td><td width="200">1977-9-1</td></tr>
<tr><td width="200">HbA1C</td><td width="200">6</td><td width="200">1978-9-13</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">55</td><td width="200">1978-9-13</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">129</td><td width="200">1978-9-13</td></tr>
<tr><td width="200">SGOT</td><td width="200">18</td><td width="200">1978-9-19</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">140</td><td width="200">1978-9-13</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">0</td><td width="200">1978-9-19</td></tr>
<tr><td width="200">Height</td><td width="200">64</td><td width="200">1978-9-13</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1978-9-19</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">129</td><td width="200">1978-9-13</td></tr>
<tr><td width="200">BUN</td><td width="200">34</td><td width="200">1978-9-19</td></tr>
<tr><td width="200">HCT</td><td width="200">31</td><td width="200">1978-9-19</td></tr>
<tr><td width="200">HGB</td><td width="200">10</td><td width="200">1978-9-19</td></tr>
<tr><td width="200">Sodium</td><td width="200">137</td><td width="200">1978-9-19</td></tr>
<tr><td width="200">Albumen</td><td width="200">3</td><td width="200">1978-9-19</td></tr>
<tr><td width="200">Creatinine</td><td width="200">4.7</td><td width="200">1978-9-19</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">6</td><td width="200">1978-9-13</td></tr>
<tr><td width="200">UrineProtein_Qualitative</td><td width="200">1088.0</td><td width="200">1977-9-16</td></tr>
<tr><td width="200">UrineProtein_Spot</td><td width="200">1,088</td><td width="200">1977-9-16</td></tr>
<tr><td width="200">Pulse</td><td width="200">70</td><td width="200">1978-9-13</td></tr>
<tr><td width="200">PLT</td><td width="200">172</td><td width="200">1978-9-19</td></tr>
<tr><td width="200">WBC</td><td width="200">7</td><td width="200">1978-9-19</td></tr>
<tr><td width="200">SGPT</td><td width="200">27</td><td width="200">1978-9-19</td></tr>
<tr><td width="200">target_HBA1c</td><td width="200">7.0</td><td width="200">1978-9-16</td></tr>
<tr><td width="200">diarrhea</td><td width="200"></td><td width="200">1978-5-11</td></tr>
<tr><td width="200">DM-Type2</td><td width="200"></td><td width="200">1978-5-11</td></tr>
<tr><td width="200">Sex</td><td width="200">Female</td><td width="200"></td></tr>
<tr><td width="200">Diabetes with renal manifestations</td><td width="200"></td><td width="200">1978-9-16</td></tr>
<tr><td width="200">Atrial_Fibrillation</td><td width="200"></td><td width="200">1978-8-24</td></tr>
<tr><td width="200">Cardiomegaly</td><td width="200"></td><td width="200">1978-9-13</td></tr>
<tr><td width="200">Race</td><td width="200">Asian_or_Pacific-Islander_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">BNP</td><td width="200">>30000</td><td width="200">1978-8-23</td></tr>
<tr><td width="200">Renovascular_Disease</td><td width="200"></td><td width="200">1978-9-19</td></tr>
<tr><td width="200">Renal_Insufficiency</td><td width="200"></td><td width="200">1978-8-25</td></tr>
<tr><td width="200">edema</td><td width="200"></td><td width="200">1978-9-18</td></tr>
<tr><td width="200">End-Stage_Renal_Disease</td><td width="200"></td><td width="200">1978-9-19</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1977-6-12</td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1978-9-16</td></tr>
<tr><td width="200">nausea</td><td width="200"></td><td width="200">1978-7-26</td></tr>
<tr><td width="200">Renal disease</td><td width="200"></td><td width="200">1978-8-25</td></tr>
</table>
<p><b>Medications:</b> aspirin(325.0) glyburide(5.0) losartan(50.0) ramipril(10.0) atenolol(25.0) lisinopril(20.0) rosiglitazone(8.0) furosemide(20.0) Insulin(0.04) clonidine(0.0) labetalol(5.0) hydralazine(100.0) hydrochlorothiazide(25.0) glipizide(5.0) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Isolated_Systolic_Hypertension</td>
<td width="200"></td>
<td width="200"> Isolated Systolic Hypertension[Treatment_Systolic_BP(140/null) && Treatment_Diastolic_BP(70/null)]()</td></tr>
<tr><td width="200">Laboratory_Test_Result_Syndrome</td>
<td width="200"></td>
<td width="200"> Hyperuricemia[Uric_Acid(8.4/1977-9-1)]()</td></tr>
<tr><td width="200">Renal_insufficiency_w_creat>=2.1</td>
<td width="200"></td>
<td width="200"> Renal Insufficiency[Creatinine(4.7/1978-9-19)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of heart failure]()</td></tr>
<tr><td width="200">Isolated_Systolic_Hypertension K >=3.5</td>
<td width="200"></td>
<td width="200"> Isolated Systolic Hypertension[presence of isolated systolic hypertension && Potassium(3.6/1978-9-19)]()</td></tr>
<tr><td width="200">Heart Failure and BP not controlled</td>
<td width="200"></td>
<td width="200"> Heart Failure[presence of heart failure && BP not adequately controlled based on most recent BPTreatment_Systolic_BP(140/null)]()</td></tr>
<tr><td width="200">ISH on HCTZ and BP not controlled</td>
<td width="200"></td>
<td width="200"> Isolated Systolic Hypertension[presence of isolated systolic hypertension && presence of HCTZ && BP not adequately controlled based on most recent BPTreatment_Systolic_BP(140/null)]()</td></tr>
<tr><td width="200">DM and BP not controlled</td>
<td width="200"></td>
<td width="200"> Diabetes[presence of DM && BP not adequately controlled based on most recent BPTreatment_Systolic_BP(140/null)]()</td></tr>
<tr><td width="200">DM BP not controlled  >=1 drug</td>
<td width="200"></td>
<td width="200"> Diabetes[BP not adequately controlled based on most recent BPTreatment_Systolic_BP(140/null) && presence of diabetes mellitus && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[Sex(Female) && Age(78.0/1970-1-1)]()</td></tr>
<tr><td width="200">On meds & Presence of strong contraindication to HCTZ or using bad drug partner</td>
<td width="200"></td>
<td width="200"> Hypertension[taking furosemide && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">Active prescription for thiazide</td>
<td width="200"></td>
<td width="200"> active prescription for thiazide[presence of thiazide diuretics]()</td></tr>
<tr><td width="200">active prescription for furosemide</td>
<td width="200"></td>
<td width="200"> active prescription for furosemide[taking furosemide]()</td></tr>
<tr><td width="200">Age > 65</td>
<td width="200"></td>
<td width="200"> age > 65 years[Age(78.0/1970-1-1)]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">taking >= 2 anti hypertensive meds</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">drug intolerance ACE/ARB OR hypotension OR renal insufficiency</td>
<td width="200"></td>
<td width="200"> drug intolerance ACE/ARB OR hypotension OR renal insufficiency[presence of renal insufficiency ICD9]()</td></tr>
<tr><td width="200">Acitve prescription for ACE and ARB</td>
<td width="200"></td>
<td width="200"> Acitve prescription for ACE and ARB[ACE I being used && Presence of ARB]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">Female and most recent creatinine  >2</td>
<td width="200"></td>
<td width="200"> Female and most recent creatinine  >2[Sex(Female) && Creatinine(4.7/1978-9-19)]()</td></tr>
<tr><td width="200">Renal-Urinary_Diseases</td>
<td width="200">1978-09-19</td>
<td width="200"> Renovascular_Disease()</td></tr>
<tr> <td width="200"></td>
<td width="200">1978-08-25</td>
<td width="200"> Renal_Insufficiency()</td></tr>
<tr> <td width="200"></td>
<td width="200">1978-08-25</td>
<td width="200"> Renal disease()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1977-06-12</td>
<td width="200"> Heart_Failure()</td></tr>
<tr> <td width="200"></td>
<td width="200">1978-09-13</td>
<td width="200"> Cardiomegaly()</td></tr>
<tr> <td width="200"></td>
<td width="200">1978-08-24</td>
<td width="200"> Atrial_Fibrillation()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1978-09-16</td>
<td width="200"> Hypertension()</td></tr>
<tr><td width="200">Endocrine_Diseases</td>
<td width="200">1978-05-11</td>
<td width="200"> DM-Type2()</td></tr>
<tr> <td width="200"></td>
<td width="200">1978-09-16</td>
<td width="200"> Diabetes with renal manifestations()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1978-05-11</td>
<td width="200"> diarrhea()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200">1978-08-23</td>
<td width="200"> BNP()
<tr> <td width="200"></td>
<td width="200">1978-09-19</td>
<td width="200"> End-Stage_Renal_Disease()
<tr> <td width="200"></td>
<td width="200">1978-09-18</td>
<td width="200"> edema()
<tr> <td width="200"></td>
<td width="200">1978-07-26</td>
<td width="200"> nausea()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> LDL< 100 mg/dL(CHD Risk Equivalent)
<p><b>Reached goal?</b> achieved(LDL_Cholesterol(65.0/1978-9-13))
<p>
<b>Goal:</b> SBP < 140 and DBP < 80(presence of diabetes mellitus)
<p><b>Reached goal?</b> failed(Treatment_Systolic_BP(140/null))
<p><b>Messages by Types</b>
<ul>
<li><b>Class II a</b>
<ul>
<li>It is reasonable to treat patients with atrial fibrillation and HF with a strategy to maintain sinus rhythm or with a strategy to control ventricular rate alone. (Level of Evidence: A)
<li>Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)
</ul>
<li><b>Class I</b>
<ul>
<li>Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
</ul>
<li><b>Class III</b>
<ul>
<li>Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage C HF</b><br>
<ul>
</ul>
<li><b> </b><br>
<ul>
<li><b>General Recommendations <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HF ICD9 code OR( signs and structural abnormality)</i> evaluate to <b> true</b> because <i>Presence of HF</i>)])
Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
It is reasonable to treat patients with atrial fibrillation and HF with a strategy to maintain sinus rhythm or with a strategy to control ventricular rate alone. (Level of Evidence: A)
Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)

<li><b>Referrals <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])
Class I
<li><b>Stage B HF action <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>hydralazine and nitrates<ul><li>preference: neutral<li>No comment</ul><li>Beta blocker for stage C heart failure(Bisoprolol, Sustained release metoprolol succinate, Carvedilol)<ul><li>preference: neutral<li>No comment</ul><li>Beta blocker Stage C with MI(Carvedilol)<ul><li>preference: neutral<li>No comment</ul><li>aldosterone antagonist<ul><li>Contraindications:  Female and most recent creatinine  >2(Female and most recent creatinine  >2[Sex(Female) && Creatinine(4.7/1978-9-19)])  Acitve prescription for ACE and ARB(Acitve prescription for ACE and ARB[ACE I being used && Presence of ARB]) <li>preference: ruled out</ul></ul><b>Considerations for adding drug: </b><ul><li>digoxin<ul><li>preference: neutral<li>No comment</ul><li>Ace_Inhibitor(Enalapril)<ul><li>Already being used<li>preference: ruled out</ul><li>ARB<ul><li>Already being used<li>preference: ruled out</ul><li>NDHP CCB<ul><li>Contraindications:  Heart_Failure(Cardiomegaly, Heart_Failure) <li>preference: ruled out</ul><li>Beta blocker stage B post MI(atenolol)<ul><li>Already being used<li>preference: ruled out</ul><li>Beta Blocker Stage B no MI<ul><li>Already being used<li>preference: ruled out</ul></ul></body></html>